Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 10, 2023 6:18pm
RE:RE:RE:Something to think about...
..and to be able do that they borrowed 32 millions dollars of worthless of monopolyLatam money paper depretiating @ 10% per months. When they can no loger borrow soon the share price will sink to $ 2
...more
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jan 10, 2023 5:42pm
RE:RE:Something to think about...
That was timely! So they repurchased another 450k shares in December.
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 10, 2023 5:07pm
RE:RE:RE:Something to think about...
Yep making money on people who are making $2 dollars a day and fighting for $5, are you dumb, deaft, blind and callus to the human tragedies takiing place in LATAM? Hundreds of
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 10, 2023 3:46pm
RE:RE:Something to think about...
Some kind of deal - even if it's small would seem logical in 2023. I know a small pharma that's getting regular requests to tie up for their heavy bank account and that's only $42 MM
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jan 10, 2023 3:38pm
RE:RE:Thanks Golden ...
If I were in a Rock N Roll band ... they'd surely be my groupies. Maybe even Chapman to my John Lennon. A little cringeworthy. : )
(6)
•••
EbbFlow88
X
View Profile
View Bullboard History
Comment by
EbbFlow88
on Jan 10, 2023 2:35pm
RE:Something to think about...
If you believe that tthe tax assessment will go our way. You can add 46M to our cash total. Making the market value of the base operations ~$250M which yields 18% cash. Separately, there
...more
(258)
•••
qwerty22
X
View Profile
View Bullboard History
Comment by
qwerty22
on Jan 10, 2023 2:23pm
RE:Thanks Golden ...
Hey Mug, just curious, what's it like to have your very own stalker? :)
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 10, 2023 1:50pm
RE:Thanks Golden ...
Know it all Doctor Mr Mugsy, why do you not talk about that all LTAM is revolting and going left wing, and no one can afford any drugs. Further why Doctor knows it al Mugsy does not ask? Has any
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 10, 2023 12:04pm
Thanks Golden ...
Did listen to Biogen's CEO speak about the Alzheimer's drug. Far from a sure thing - lots of hurdles. He's positive about it but that's his job. Getting medicare coverage isn't a
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 07, 2023 8:09am
Do not believe Mugsy read facts for yourself
Listen to article Length5 minutes
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Jan 07, 2023 7:58am
RE:Don't let Biogen's AD drug scare you ...
GUD spent over 200 milion to buy an old dug that is obsolte and to sell it to poor LATAM people while the rich in. lATAM will travel to the US and get the real biogen drug. As usual
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Jan 06, 2023 10:33pm
Don't let Biogen's AD drug scare you ...
Just like I warned that Biogen's firs AD drug wasn't going to matter. I'm going to tell you that Biogen's second AD drug doesn't matter. You have to be able to understand what'
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 06, 2023 3:29pm
More bad news for GUD
https://www.cnbc.com/2023/01/06/alzheimers-disease-fda-decision-on-biogen-eisai-treatment-lecanemab.html?__source=newsletter%7Cbreakingnews
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Jan 06, 2023 12:31pm
How Lula is investor friendly? Houch
https://www.ft.com/content/8608bab6-1ee4-4cfb-8a69-ee7caa4320d8
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >